
13.87 Delayed Data As of 3:59pm ET | ![]() Today’s Change | 12.54 Today|||52-Week Range 33.49 | -53.14% Year-to-Date |
The 11 analysts offering 12-month price forecasts for Bicycle Therapeutics PLC have a median target of 46.00, with a high estimate of 60.00 and a low estimate of 33.00. The median estimate represents a +231.65% increase from the last price of 13.87.
The current consensus among 13 polled investment analysts is to Buy stock in Bicycle Therapeutics PLC. This rating has held steady since November, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.